McMillion Capital Management’s Eli Lilly LLY Stock Holding History

McMillion Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	-$11K	–	280
2019 Q2	$11K	Buy	+100	New	+$11.8K	0.01%	191
2016 Q3	–	Sell	-37,126	Closed	-$2.92M	–	62
2016 Q2	$2.92M	Sell	37,126 -8,185	-18%	-$616K	2.26%	20
2016 Q1	$3.26M	Sell	45,311 -8	-0%	-$605	2.42%	17
2015 Q4	$3.82M	Sell	45,319 -898	-2%	-$74.5K	2.86%	8
2015 Q3	$3.87M	Sell	46,217 -4,825	-9%	-$407K	2.99%	7
2015 Q2	$4.26M	Sell	51,042 -1,770	-3%	-$135K	2.65%	10
2015 Q1	$3.84M	Sell	52,812 -2,018	-4%	-$144K	2.29%	17
2014 Q4	$3.78M	Buy	54,830 +115	+0.2%	+$7.76K	2.17%	16
2014 Q3	$3.55M	Buy	+54,715	New	+$3.46M	2.08%	19

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

McMillion Capital Management's LLY Position: Q3 2019 in Review

McMillion Capital Management sold out of Eli Lilly (LLY) in Q3 2019, closing a stake of 100 shares — an estimated $11K sold.

McMillion Capital Management first reported a position in LLY in Q3 2014 and held it in 9 quarters. The position peaked at $4.26M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

McMillion Capital Management reported no remaining Eli Lilly position as of Q3 2019 after selling out during the quarter.
McMillion Capital Management sold 100 Eli Lilly shares in Q3 2019, an estimated $11K.
McMillion Capital Management first reported a position in Eli Lilly in Q3 2014 and held it in 9 quarters.
McMillion Capital Management's Eli Lilly position peaked at $4.26M in Q2 2015.
1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on McMillion Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.